STADA strengthens distribution in Italy by acquiring majority stake in Pharmajani
The aim of shareholders is to further expand the company's operations and to significantly strengthen the distribution capabilities of STADA's Italian subsidiaries EG SpA and Crinos SpA. To this end, the acquired company's headquarters will be moved to Milan, where EG SpA is based; at the same time, the company will change its name to New Pharmajani SpA (NPA).
NPA sells various licensed products in pharmacies, currently employing a salesforce of 45 freelancers. STADA's new subsidiary will expand its present regional focus on northwestern Italy into a nationwide presence and, in addition to STADA's products, will continue to sell other companies' drugs. STADA will therefore consolidate the aquired sales of NPA as part of its Commercial Business segment. This acquisition provides STADA with more direct access to Italian pharmacies and will enable it to step up the sale and marketing of its own product ranges through this distribution channel by using a Group-controlled company.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.